Stockscreener 앱 받기
1.22
6.09%
0.07
전일 마감가:
$1.15
열려 있는:
$1.21
하루 거래량:
2.12M
Relative Volume:
3.12
시가총액:
$34.06M
수익:
-
순이익/손실:
$-13.76M
주가수익비율:
-1.3118
EPS:
-0.93
순현금흐름:
-
1주 성능:
+3.39%
1개월 성능:
+8.93%
6개월 성능:
+11.93%
1년 성능:
-5.43%
1일 변동 폭
$1.18
$1.275
1주일 범위
$1.10
$1.98
52주 변동 폭
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
NRSN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.22 | 34.06M | 0 | -13.76M | 0 | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurosense Therapeutics Ltd 주식(NRSN)의 최신 뉴스
will neurosense therapeutics ltd. equity warrant bounce back from current supportJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - newser.com
NeuroSense Therapeutics Secures $500,000 in Premium Private Placement - MSN
Has NeuroSense Therapeutics Ltd. Equity Warrant formed a bullish divergenceJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
Live market analysis of NeuroSense Therapeutics Ltd. Equity Warrant2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
How high can NeuroSense Therapeutics Ltd. stock goJuly 2025 Decliners & Weekly Top Gainers Alerts - newser.com
NeuroSense Therapeutics Ltd. Equity Warrant stock outlook for YEARJuly 2025 PostEarnings & Verified Chart Pattern Signals - Newser
Can NeuroSense Therapeutics Ltd. Equity Warrant rally from current levelsTrend Reversal & Safe Investment Capital Preservation Plans - Newser
Will NeuroSense Therapeutics Ltd. price bounce be sustainableQuarterly Trade Report & Expert Verified Stock Movement Alerts - Newser
Custom strategy builders for tracking NeuroSense Therapeutics Ltd. Equity Warrant2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
Applying Wyckoff theory to NeuroSense Therapeutics Ltd. Equity Warrant stockMarket Growth Report & Free Long-Term Investment Growth Plans - Newser
What earnings revisions data tells us about NeuroSense Therapeutics Ltd. Equity WarrantMarket Performance Summary & Technical Confirmation Trade Alerts - Newser
What machine learning models say about NeuroSense Therapeutics Ltd. Equity WarrantJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
can neurosense therapeutics ltd. recover in the next quarterJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser
What MACD and RSI say about NeuroSense Therapeutics Ltd.July 2025 WrapUp & Entry Point Strategy Guides - Newser
Detecting support and resistance levels for NeuroSense Therapeutics Ltd.Portfolio Risk Report & Weekly High Conviction Trade Ideas - Newser
What the charts say about NeuroSense Therapeutics Ltd. Equity Warrant todayPortfolio Risk Report & Fast Gain Swing Alerts - Newser
Is NeuroSense Therapeutics Ltd. stock reversal real or fakeCPI Data & Community Consensus Stock Picks - Newser
Does NeuroSense Therapeutics Ltd. qualify in momentum factor screeningMarket Growth Report & Community Consensus Picks - Newser
Understanding NeuroSense Therapeutics Ltd.’s price movementJuly 2025 Review & Weekly Watchlist for Consistent Profits - Newser
NeuroSense Therapeutics Ltd. Equity Warrant stock trend outlook and recovery pathPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
Health Care Stocks Tumble While Neurosense Defies The Drop - Finimize
Is NeuroSense Therapeutics Ltd. Equity Warrant still worth holding after the dipWeekly Profit Report & Community Trade Idea Sharing - Newser
Sector Update: Health Care - MarketScreener
NeuroSense Reports Positive Initial Results for Alzheimer’s Drug Candidate - TipRanks
Neurosense Therapeutics Shares Up After Initial Phase 2 Data of Alzheimer's Disease Treatment Show Enhanced Neuroplasticity - MarketScreener
Neurosense's drug candidate shows early signals of benefit in Alzheimer's patient-derived neurons - MarketScreener
NeuroSense's Drug Candidate Shows Early Signals of Benefit in Alzheimer's Patient-Derived Neurons - PR Newswire
NeuroSense Therapeutics Announces Annual General Meeting for September 2025 - MSN
Automated trading signals detected on NeuroSense Therapeutics Ltd. Equity Warrant - Newser
Published on: 2025-09-10 05:46:58 - Newser
Combining price and volume data for NeuroSense Therapeutics Ltd.Market Trend Report & Reliable Price Breakout Alerts - Newser
Will earnings trigger a reversal in NeuroSense Therapeutics Ltd.Portfolio Risk Summary & Pattern Based Trade Signal System - Newser
How to build a dashboard for NeuroSense Therapeutics Ltd. Equity Warrant stockJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser
Will a bounce in NeuroSense Therapeutics Ltd. Equity Warrant offer an exitGap Down & Long-Term Safe Investment Plans - Newser
Full technical analysis of NeuroSense Therapeutics Ltd. Equity Warrant stockShort Setup & Accurate Buy Signal Alerts - Newser
Can momentum traders help lift NeuroSense Therapeutics Ltd.Take Profit & Verified Swing Trading Watchlist - Newser
Top chart patterns to watch in NeuroSense Therapeutics Ltd. Equity Warrant2025 Volatility Report & Growth Focused Entry Point Reports - Newser
Why is NeuroSense Therapeutics Ltd. stock going downTrade Performance Summary & Free Real-Time Volume Trigger Notifications - Lancaster City Council
Is NeuroSense Therapeutics Ltd. stock a value trap2025 Sector Review & Daily Growth Stock Tips - Lancaster City Council
Does NeuroSense Therapeutics Ltd. Equity Warrant have strong fundamentals2025 Trade Ideas & Community Verified Watchlist Alerts - Lancaster City Council
Will NeuroSense Therapeutics Ltd. face regulatory challengesWeekly Trend Recap & Daily Growth Stock Investment Tips - Lancaster City Council
Can NeuroSense Therapeutics Ltd. grow without dilutionJuly 2025 Reactions & Low Drawdown Momentum Ideas - Lancaster City Council
Chart based analysis of NeuroSense Therapeutics Ltd. Equity Warrant trendsTrade Signal Summary & Weekly High Conviction Trade Ideas - Newser
Multi asset correlation models including NeuroSense Therapeutics Ltd.2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - Newser
Is NeuroSense Therapeutics Ltd. Equity Warrant’s ROE strong enough2025 Big Picture & Capital Efficient Trade Techniques - beatles.ru
Is it time to cut losses on NeuroSense Therapeutics Ltd.July 2025 Weekly Recap & Fast Gain Stock Trading Tips - Newser
Is NeuroSense Therapeutics Ltd. Equity Warrant part of any ETFJuly 2025 Recap & AI Driven Stock Reports - beatles.ru
NeuroSense Therapeutics Ltd. Facing Inflection Point in Trend AnalysisQuarterly Risk Review & Fast Gaining Stock Strategy Reports - beatles.ru
NeuroSense Therapeutics (NRSN) Stock Price, News & Analysis - MarketBeat
Using AI based signals to follow NeuroSense Therapeutics Ltd. Equity WarrantEarnings Beat & Weekly High Potential Stock Alerts - Newser
Can NeuroSense Therapeutics Ltd. Equity Warrant outperform under higher oil pricesDay Trade & Reliable Price Action Trade Plans - خودرو بانک
Neurosense Therapeutics Ltd (NRSN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.10%
자본화:
|
볼륨(24시간):